Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123876423 | 12387642 | 3 | F | 20160825 | 20160520 | 20160829 | EXP | FR-ROCHE-1760504 | ROCHE | , HAMMEL P, HUGUET F, VAN LAETHEM J, GOLDSTEIN D, GLIMELIUS B, ARTRU I, BORBATH, BOUCHE O, SHANNON J, ANDRE T, BONNETAIN F AND LOUVET C. COMPARISON OF CHEMORADIOTHERAPY (CRT) AND CHEMOTHERAPY (CT) IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC CANCER (LAPC) CONTROLLED AFTER 4 MONTHS OF GEMCITABINE WITH OR WITHOUT ERLOTINIB: FINAL RESULTS OF THE INTERNATIONAL PHASE III LAP 07... UNITED EUROPEAN GASTROENTEROLOGY JOURNAL 2013 OCT;1 (1 SUP1):A37-. | 0.00 | Y | 0.00000 | 20160829 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123876423 | 12387642 | 1 | PS | Erlotinib | ERLOTINIB | 1 | Oral | DOSE: DAILY DOSE OF ERLOTINIB WAS INCREASED TO 150MG | U | 53728 | |||||||||
| 123876423 | 12387642 | 2 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | 800 | MG/M**2 | ||||||||
| 123876423 | 12387642 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | U | 0 | 1000 | MG/M**2 | INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123876423 | 12387642 | 1 | Pancreatic carcinoma |
| 123876423 | 12387642 | 2 | Pancreatic carcinoma |
| 123876423 | 12387642 | 3 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123876423 | 12387642 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123876423 | 12387642 | Acne | |
| 123876423 | 12387642 | Dry skin | |
| 123876423 | 12387642 | Febrile neutropenia | |
| 123876423 | 12387642 | Mucosal inflammation | |
| 123876423 | 12387642 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |